Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracanal medicaments for post-root canal pain in symptomatic apical periodontitis
ACTRN12622001513707Phase 4Completed
- Sponsor
- Qassim University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calcium hydroxide, chlorhexidine and metronidazole + ciprofloxacin + minocycline in apical periodontitis (AP) (4 arms), sponsored by Qassim University. Primary endpoint: Post-root canal preparation pain. Started Apr 2021; status: completed.
02
Drugs
calcium hydroxidechlorhexidinemetronidazole + ciprofloxacin + minocycline
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on ACTRN12622001513707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001513707.